Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib may effectively treat oral lichen planus.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.